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Abstract
Obesity-associated low-grade chronic inflammation plays an important role in the development
of insulin resistance. The membrane lipid transporter ATP-binding cassette transporter A1
(ABCA1) promotes formation of nascent HDL particles. ABCA1 also dampens macrophage
inflammation by reducing cellular membrane cholesterol and lipid raft content. We tested the
hypothesis that myeloid-specific ABCA1 deletion may exacerbate insulin resistance by
increasing the obesity-associated chronic low-grade inflammation. Myeloid cell-specific ABCA1
knockout (MSKO) and wild-type (WT) mice developed obesity, insulin resistance, mild
hypercholesterolemia, and hepatic steatosis to a similar extent with a 45% high-fat (HF) diet
feeding or after crossing into the ob/ob background. Resident peritoneal macrophages and
stromal vascular cells from obese MSKO mice accumulated significantly more cholesterol.
Relative to chow, HF diet markedly induced macrophage infiltration and inflammatory cytokine

expression to a similar extent in adipose tissue of WT and MSKO mice. Among proinflammatory cytokines examined, only IL-6 was highly upregulated in MSKO-ob/ob versus
ob/ob mouse peritoneal macrophages, indicating a nonsignificant effect of myeloid ABCA1
deficiency on obesity-associated chronic inflammation. In conclusion, myeloid-specific ABCA1
deficiency does not exacerbate obesity-associated low-grade chronic inflammation and has
minimal impact on the pathogenesis of insulin resistance in both HF diet-induced and genetically
obese mouse models.
Keywords: cholesterol, macrophage, inflammation, obesity, high-fat

In the past decade, obesity-associated chronic low-grade inflammation has been recognized as a
major cause of insulin resistance and type 2 diabetes. For example, overexpansion of adipose
tissues increases the production of pro-inflammatory cytokines, such as tumor necrosis factor-α
(TNF-α) (1), and chemokines, such as monocyte chemoattractant protein-1 (MCP-1) (2). TNF-αactivated c-Jun N-terminal kinase (JNK) impairs insulin signaling, which contributes to insulin
resistance (3). MCP-1 recruits immune cells, especially macrophages (40% of infiltrated immune
cells), to adipose tissue, exacerbating inflammation and insulin resistance (4). Interestingly, Tolllike receptor 4 (TLR4), a pathogen-associated molecular pattern receptor, has been implicated as
a link between inflammation and insulin resistance by functioning as a receptor for saturated fatty
acids (5–7). Genetic deletion of key components of the TLR4 signaling pathway, such as TLR4
(8), JNK1 (9), or inhibitor of NF-κB-kinase β (IKKβ) (10) in hematopoietic or myeloid cells further
established the mechanistic link between macrophage inflammation and insulin resistance.
ATP-binding cassette transporter A1 (ABCA1), a member of a large family of membrane
transporters, effluxes free cholesterol (FC) and phospholipids across the plasma membrane to
combine with apolipoprotein A-I, forming nascent high density lipoprotein (HDL) particles (11,
12). Mutations that inactivate ABCA1 lead to Tangier disease, a disorder characterized by near
absence of HDL, elevated plasma triglycerides (TGs), reduced low density lipoprotein
concentrations, and increased storage of cholesteryl esters (CEs) in macrophages (13–15). Insulin
resistance has not been documented in people with Tangier disease, perhaps because the disease
is so rare (16). However, ABCA1 single nucleotide polymorphisms are associated with altered
glucose metabolism and insulin resistance in humans (17–20). Of interest, leukocyte ABCA1 gene
expression is associated with fasting glucose concentrations in normoglycemic men, and reduced
leukocyte ABCA1 gene expression is associated with type 2 diabetes (21, 22). To date, only one
study has directly linked ABCA1 expression to hyperglycemia, reporting that pancreatic β cellspecific ABCA1 deletion results in defective insulin release from islet cells (23). Whether deletion
of ABCA1 expression in other cell types, such as macrophages, alters glucose metabolism is
unknown.
Using myeloid cell (macrophage and neutrophil)-specific ABCA1 knockout (MSKO) mice, we
demonstrated that macrophages from MSKO mice have a significant increase in FC and are more
responsive to pro-inflammatory stimuli [e.g., lipopolysaccharide (LPS)] in vivo and in vitro
compared with wild-type (WT) mice (24). This response was mediated through the TLR and
myeloid differentiation primary-response protein 88 (MyD88)-dependent pathway and was

independent of alterations in plasma lipid concentrations (24). Hypersensitivity to LPS is most
likely due to increased lipid raft content and increased trafficking of TLR4 into plasma membrane
lipid rafts in MSKO mouse macrophages (25). Furthermore, MSKO mice challenged with the
Listeria monocytogenes cleared the bacterium better than WT mice (26). These studies clearly
demonstrated a regulatory role of myeloid ABCA1 in macrophage inflammation and innate
immunity.
Based on the documented relationship between macrophage inflammation and insulin resistance,
we hypothesized that myeloid-specific ABCA1 deficiency may exacerbate obesity-induced
chronic inflammation and insulin resistance in mice fed a HF diet or crossed into the leptindeficient ob/ob background. However, MSKO and WT mice developed obesity, adipose
inflammation, and insulin resistance to a similar extent, suggesting that myeloid ABCA1
expression does not significantly worsen obesity-induced chronic inflammation and insulin
resistance.

METHODS
Animals
WT (ABCA1+/+) and MSKO (ABCA1−M/−M) mice were generated as described previously (24,
25). Mice were backcrossed into the C57BL/6 background for six generations before use in these
studies and housed in a specific pathogen-free facility with a 12 h light/dark cycle. Experiments
were conducted in conformity with the Public Health Service Policy on Humane Care and Use of
Laboratory Animals, and the experimental protocol was approved by the Wake Forest University
Animal Care and Use Committee. At 8 weeks of age, male mice were switched from chow to a
HF diet containing 45% of energy as lard and 0.015% cholesterol for 16–24 weeks. The HF diet
was made by our institutional diet kitchen (see detailed diet composition in supplementary Table
I). Body weight (BW) was measured biweekly. To generate MSKO-ob/ob mice, MSKO mice were
first bred with heterozygous ob/ob (ob/+) mice. The resulting double heterozygous MSKO-ob/+
mice were intercrossed to generate ob/+ or MSKO-ob/+ mice, which were then intercrossed to
generate ob/ob or MSKO-ob/ob mice, respectively. Ob/ob and MSKO-ob/ob male mice were fed
chow for 14–15 weeks for the described studies.

Cell culture
Peritoneal macrophages were harvested from mice by flushing the peritoneal cavity with cold PBS.
The peritoneal cells were plated in RPMI media containing 100 U/ml penicillin, 100 μg/ml
streptomycin, and 1% Nutridoma SP media (Roche Applied Science). After a 2 h incubation,
floating cells were removed by washing with PBS and adherent macrophages were used for
experiments.

Plasma lipid, glucose, and insulin analysis
Blood samples were taken from tail veins following a 4 h fast during the light cycle (chow phase)
before, and at 2–4 week intervals after initiation of HF diet feeding. Plasma cholesterol (Wako)

and TGs (Roche) were determined by enzymatic analysis according to the manufacturer's
instructions. Plasma glucose levels were measured using a glucometer (Ascensia Contour, Bayer).
Plasma insulin levels were measured by ELISA (Crystal Chem, Inc., Downers Grove, IL). For fed
and overnight fasting plasma samples, blood was collected by tail vein at 9:00 AM in ad libitum
fed mice (fed) or in mice fasted during the dark cycle for 15 h (5:00 PM–8:00 AM).

Hepatic lipid analysis
Liver lipids were extracted with chloroform:methanol (2:1) and the extract was used for enzymatic
assays (cholesterol, Wako; TG, Roche). Data were normalized to liver protein mass, measured by
the Lowry protein assay.

Glucose homeostasis analysis
Glucose tolerance tests (GTTs) and insulin tolerance tests (ITTs) were done after 12–20 weeks of
HF diet consumption or with ob/ob mice at 13–14 weeks of age. Briefly, for GTTs, mice were
fasted overnight before intraperitoneal (ip) injection of 1 g glucose/kg BW. Blood was collected
before and after injection (0, 15, 30, 60, and 120 min) to measure glucose concentrations using a
commercial glucose monitor. One week later, the same groups of mice were used for ip injection
of 1.5 U of regular human insulin/kg BW (HF diet-fed mice) or 3 U/kg BW (ob/ob mice) after a 5
h fast. Blood glucose concentrations were measured at 0, 15, 30, 60, and 120 min after injection.

Real-time PCR
Total RNA in peritoneal macrophages and white adipose tissue was extracted using Trizol
(Invitrogen) and RNeasy lipid tissue kits (Qiagen), respectively, according to the manufacturer's
protocols. cDNA preparation and real-time PCR were conducted as described previously (24).

Immunohistochemistry staining
Epididymal fat tissue sections were incubated with the primary antibodies to CD68 (abD Serotec)
or cleaved caspase-3 (Cell Signaling), followed by the biotinylated secondary antibody. The
staining was visualized using ABC reagent (ABC vector kit; Vector) and DAB substrate
chromogen (Dako). The area of fat sections covered by CD68+ or cleaved caspase-3+ cells was
measured using Image-Pro software to quantify the percentage of positive staining cells in adipose
tissue.

Stromal vascular cell isolation
Stromal vascular cells were fractioned according to the procedure described by Brown et al. (27).
Briefly, epididymal fat was minced and enzymatically digested for 45 min with 5 ml/g tissue of
collagenase type I (1 mg/ml, Worthington Biochemical Corporation) media. The digestion mixture
was filtered through a 100 μm cell strainer and stromal vascular cells were pelleted by
centrifugation (3,000 rpm for 10 min). The stromal vascular fraction (SVF) was then used for flow
cytometry.

Flow cytometry
After blocking the Fcγ receptor with purified anti-mouse CD16/CD32 antibody (Fcγ receptor
III/II; BD Biosciences), SVF cells were incubated at 4°C for 30 min with isotype controls or the
following Abs: PE-anti-F4/80 (BM8; BD Pharmingen), PE-Cy7-anti-CD11c (HL3; BD
Pharmingen), and Alexa Fluor 647-anti-CD206 (MR5D3; AbD Serotec). Cell fluorescence was
measured using a FACSCanto II flow cytometer and data analyzed with FlowJo software.

Cholesterol content of macrophages and stromal vascular cells
Macrophages or stromal vascular cells isolated from adipose tissue were extracted with
isopropanol (including 5α-cholestane as internal standard) at room temperature overnight and
analyzed for cholesterol content by gas-liquid chromatography (27).

Statistical analysis
Data are presented as the mean ± SEM unless indicated otherwise. Differences were compared
with two-tailed Student's t-test or one-way ANOVA using GraphPad Prism software. P < 0.05 was
considered statistically significant.

RESULTS
Macrophages from MSKO versus WT obese mice had significantly more
cholesterol accumulation, but comparable inflammatory cytokine expression
MSKO macrophages have increased plasma membrane FC and lipid rafts, resulting in increased
response to TLR4 stimulation (LPS) compared with WT cells (24). Saturated fatty acids also
activate TLR4 and induce chronic inflammation in the setting of obesity (5–7). We hypothesized
that increased dietary saturated fatty acids (i.e., HF diet), functioning as TLR4 agonists, might
increase inflammation during diet-induced obesity, worsening development of insulin resistance
in MSKO versus WT mice. To test this possibility, we first measured cholesterol content in the
resident peritoneal macrophages from obese mice. Consistent with our previous findings,
macrophages from HF diet-fed MSKO mice (Fig. 1A, C) or chow-fed MSKO-ob/ob mice (Fig.
1B, D) had significantly more FC and CE accumulation compared with their WT counterparts.
However, similar inflammatory cytokine gene expression was observed for macrophages from 24
week HF diet-fed WT and MSKO mice (Fig. 1E). Among the examined cytokines, only IL-6 was
upregulated in macrophages from chow-fed MSKO-ob/ob versus ob/ob mice (Fig. 1F). In addition,
the expression of TLR4 and its lipid-binding coreceptor CD36 (28) did not differ between
genotypes (Fig. 1G, H). These data suggest that despite significant increases in macrophage
cholesterol accumulation resulting from ABCA1 deficiency, HF diet feeding was not sufficient to
stimulate pro-inflammatory activation of macrophages in vivo.

Myeloid-specific ABCA1 deficiency does not worsen insulin resistance in HF dietfed mice or chow-fed ob/ob mice

Obesity-associated low-grade chronic inflammation underlies the pathogenesis of type 2 diabetes
and insulin resistance (29, 30). Macrophage ABCA1 dampens pro-inflammation via
downregulating MyD88-dependent TLR signaling (24, 25). We hypothesized that myeloidspecific ABCA1 deficiency may exacerbate chronic inflammation and insulin resistance
associated with diet-induced or genetically obese mice. To test this hypothesis, we first fed the WT
and MSKO male mice a HF diet containing 45% of energy as lard and 0.015% cholesterol. When
challenged with the HF diet, WT and MSKO mice gained similar BW over the 24 week diet
feeding period (Fig. 2A). Liver and fat mass were comparable between genotypes after 24 weeks
of diet consumption (supplementary Fig. IA, B).
We then assessed several key parameters of glucose homeostasis in WT and MSO mice. Blood
glucose concentrations after a 4 h fast were comparable between both groups of mice (Fig. 2B).
MSKO mice also exhibited similar plasma glucose clearance (GTT) compared with WT mice (Fig.
2C). Consistent with this finding, the ability of insulin to lower blood glucose concentrations
during ITTs was equivalent in both groups of mice (Fig. 2D). We next measured plasma insulin
concentrations in overnight-fasted and fed mice; again, no differences were observed between
genotypes (Fig. 2E, F). Comparable glucose homeostasis between the two genotypes also occurred
with prolonged diet feeding (e.g., 12–24 weeks) using different sets of mice. Adding cholesterol
(0.2%) to the HF diet did not significantly alter the phenotype (data not shown). Similar outcomes
were also observed for HF diet-fed female mice (data not shown). Together, our data suggest that
myeloid cell-specific ABCA1 deletion does not affect the development of systemic insulin
resistance in the presence of HF diet-induced obesity.
Next, we tested our hypothesis using an early-onset genetic obesity mouse model by crossing
MSKO mice into the ob/ob background. At 8 and 14 weeks of age, ob/ob and MSKO-ob/ob mice
had comparable BWs (Fig. 3A, B). No differences in liver or fat mass were observed between
genotypes (supplementary Fig. IC, D). A GTT was performed when mice were 13 weeks old,
followed by an ITT the next week. Due to the low yield of the MSKO-ob/ob mice, we combined
the data from three sets of mice by normalizing data to baseline values. Similar to the HF diet
study, we saw no differences in the GTTs and ITTs for ob/ob and MSKO-ob/ob mice (Fig. 3C, D),
indicating comparable systemic insulin resistance. Similar plasma insulin concentrations (Fig. 3E,
F) further confirmed that insulin resistance did not differ between genotypes.

Myeloid-specific ABCA1 deficiency does not worsen adipose tissue inflammation
We next examined the inflammatory status in fat, an important insulin target tissue. We first
measured expression of F4/80 and CD68 (macrophage markers) in epididymal fat from HF dietfed mice (17 weeks). Compared with chow, the HF diet significantly increased F4/80 and CD68
expression in adipose tissue, indicating macrophage infiltration into fat tissue (Fig. 3A).
Unexpectedly, MSKO versus WT fat had significantly lower F4/80 expression and a trend toward
less CD68 expression. Furthermore, immunohistochemistry staining of macrophages using CD68
antibody revealed that CD68+ cells in MSKO adipose tissues were greatly reduced compared with
WT (Fig. 4B), indicating significantly less macrophage infiltration into fat. The comparable level
of cleaved caspase-3 in adipose tissues (supplementary Fig. IIA, B) rules out a major role for
apoptosis in the differential accumulation of macrophages between genotypes. Interestingly, this

difference was not observed with a longer period of HF diet feeding (24 weeks, supplementary
Fig. IIIA).
Obesity induces a phenotypic switch from M2-polarized state (alternatively activated) to an M1
(classically activated) pro-inflammatory state in adipose macrophages (31). We examined
expression of the M1 type of inflammatory cytokine/chemokine and M2 macrophage markers in
fat. Feeding the HF diet for 17 weeks significantly induced pro-inflammatory cytokine (TNF-α)
or chemokine (MCP-1) expression in adipose tissues compared with chow (Fig. 4C). However, no
genotypic differences were observed between the chow-fed or HF diet-fed mice (Fig. 4C). Not
surprisingly, the expression of M2 macrophage markers did not show any difference between
genotypes (Fig. 4D). Again, no significant difference was observed in TLR4 or CD36 expression
between genotypes (supplementary Fig. IIIB). Increasing the duration of HF diet feeding from 17
to 24 weeks did not significantly increase adipose inflammation in MSKO versus WT mice
(supplementary Fig. IIIC).
Next, we examined the macrophage infiltration and inflammatory cytokine expression in ob/ob
mouse adipose tissue. Flow cytometry revealed that chow-fed MSKO-ob/ob versus ob/ob mice
had significantly less (F4/80+) and M1 (F4/80+CD11C+), but similar M2 (F4/80+CD206+)
macrophage infiltration into fat (Fig. 5A). Furthermore, MSKO-ob/ob versus ob/ob mice had
similar levels of IL-1β, TNF-α, and MCP-1 mRNA expression and a trend toward decrease in IL6 and IL-12p40 mRNA expression in fat tissue (Fig. 5B). Note that similar to peritoneal
macrophages, stromal vascular cells from MSKO-ob/ob fat had significantly higher FC (23%
increase) and CE (254% increase) accumulation relative to their WT counterparts (Fig. 5C). Thus,
our data suggest that myeloid cell-specific ABCA1 deletion enhances cholesterol accumulation in
adipose macrophages; however, it does not enhance obesity-induced macrophage infiltration or
chronic inflammation in adipose tissue.

Myeloid cell-specific ABCA1 deficiency does not alter plasma and liver lipid
profiles in HF diet-induced or genetically-induced obese mice
To determine whether ABCA1 deficiency in myeloid cells affects lipid homeostasis in HF dietfed or chow-fed ob/ob obese mice, we examined the plasma and liver lipid concentrations. There
was no genotypic difference in plasma total cholesterol (TC) and TG concentrations during the 24
weeks of HF diet feeding (Fig. 6A, C) or after mice were crossed into the ob/ob background (Fig.
6B, D). We also saw comparable levels of hepatic TC (Fig. 6E, F), FC, and CE (data not shown)
accumulation between HF diet-fed WT and MSKO mice. WT and MSKO mice developed hepatic
steatosis to a similar extent when fed a HF diet for 24 weeks (Fig. 6G) or crossed into the ob/ob
background (Fig. 6H), respectively. Together, these data suggest that myeloid cell-specific
ABCA1 deletion does not significantly affect plasma and liver lipid metabolism in the setting of
obesity-induced insulin resistance.

DISCUSSION
Obesity and insulin resistance are chronic low-grade inflammatory diseases associated with
macrophage accumulation and activation in adipose tissue (29, 30). We previously demonstrated
that myeloid cell-specific deletion of ABCA1 results in increased macrophage inflammatory

response to TLR agonists (24), and human studies suggest an association between ABCA1 single
nucleotide polymorphisms, leukocyte ABCA1 expression, and insulin resistance (17–22).
However, whether there is a link between macrophage ABCA1-regulated innate immunity and
insulin resistance is unknown. In the present study, HF diet-fed MSKO mice and chow-fed MSKOob/ob mice did not exhibit exacerbated obesity-associated chronic inflammation or insulin
resistance compared with their WT counterparts, despite a significant increase in cholesterol
content in both resident peritoneal macrophages and adipose stromal vascular cells that
accompanies ABCA1 deletion. Our results suggest that increased dietary saturated fatty acid intake
(i.e., HF diet feeding) is not sufficient to induce an augmented inflammatory response and insulin
resistance in MSKO mice compared with their WT counterparts.
Macrophages play a central role in HF diet-induced obesity and subsequent development of
systemic insulin resistance through secretion of pro-inflammatory cytokines that act on local
tissues or circulate to distal tissues. The inflammatory cytokines then block insulin receptor
signaling by serine phosphorylation of insulin-like substrate, interfering with its ability to engage
in insulin receptor signaling (32). During development of diet-induced obesity, saturated fatty
acids can activate TLR4, triggering a low-grade inflammatory state in macrophages and other cell
types, such as adipose tissue and muscle (7, 8). Deletion of TLR4 in bone marrow-derived cells
blunts the macrophage and adipose tissue response to dietary fatty acids and protects mice from
HF diet-induced insulin resistance (8). Deletion of hematopoietic cell JNK1 (a key component of
the TLR4 signaling pathway) attenuates inflammation in metabolic tissues and improves insulin
sensitivity in HF diet-fed mice (9). Moreover, myeloid-specific IKKβ deficiency improves
systemic insulin sensitivity in mice on a HF diet (10), suggesting a causative link between
increased macrophage inflammation and insulin resistance.
Our previous studies reported that myeloid-specific ABCA1 deficiency exacerbates macrophage
inflammatory response to a moderate LPS dose in vivo (3 mg/kg) and in vitro (100 ng/ml), and
this response was mediated through a MyD88-dependent TLR4 pathway (24). Unstimulated
resting macrophages were indistinguishable between WT and MSKO mice, except for a small
(∼10%) but significant increase in cellular FC. Furthermore, MSKO mice cleared infection with
L. monocytogenes more efficiently than WT mice (26). Collectively, these studies clearly establish
a regulatory role for myeloid ABCA1 in acute macrophage inflammation and innate immunity. In
addition, leukocyte ABCA1 expression protects against atherosclerosis, a chronic disease with
well-characterized inflammatory components (33–35). Based on the causative association between
macrophage inflammation and insulin resistance, we hypothesized that myeloid-specific ABCA1
deficiency would exacerbate obesity-associated chronic inflammation, worsening insulin
resistance. However, MSKO and WT mice developed obesity, insulin resistance, and mild hepatic
steatosis to a similar extent with HF diet feeding. Relative to chow, HF diet feeding markedly
induced macrophage infiltration into adipose tissue and inflammatory cytokine expression.
However, we did not observe enhanced macrophage infiltration and adipose inflammation in
MSKO versus WT mice after a HF diet feeding. Similar data were obtained with chow-fed MSKO
mice crossed into the ob/ob background. Consistent with our previous findings, macrophages from
HF diet-fed MSKO versus WT mice accumulated significantly more cholesterol, but cytokine and
chemokine gene expression was similar to WT macrophages. Therefore, myeloid-specific ABCA1
deficiency impairs cholesterol efflux, leading to intracellular cholesterol accumulation, but does

not exacerbate obesity-associated low-grade chronic inflammation and does not lead to insulin
resistance.
Our study shows that absence of myeloid cell ABCA1 expression is not sufficient to mount an
exaggerated inflammatory response in the setting of obesity and does not result in insulin
resistance. In our previous study, an increased macrophage inflammatory response in ABCA1deficient versus WT macrophages was triggered by a moderate dose of LPS in vivo or in vitro,
and not observed in nonstimulated macrophages (24). There may be several explanations for the
lack of an exaggerated inflammatory response with HF diet feeding in our current study. First, the
amount of saturated fatty acid necessary to differentially activate an inflammatory response in
macrophages with and without ABCA1 expression may have been insufficient. Inflammatory
stimulation of macrophages via TLR4 requires high concentrations of saturated fatty acids (∼500
μM) in vitro or intravenous infusion of high amounts of TGs (∼17 μmol/h) in vivo (7). Second,
previous studies demonstrating TLR4-specific activation of inflammation by HF diets used mice
lacking TLR4 globally (7) or in bone marrow cells (8), leaving open the possibility that cells other
than macrophages could have contributed to the exacerbated inflammation and systemic insulin
resistance. In fact, to our knowledge, there are only two examples in which myeloid-specific
deletion of genes (IKK-β or JNK) involved in canonical inflammatory signaling pathways resulted
in HF-induced systemic insulin resistance (10, 36). However, IKK-β and JNK are directly involved
in inflammatory signaling, whereas ABCA1 indirectly affects TLR signaling by increasing
membrane lipid raft content, resulting in more TLR4 in lipid rafts (25). In addition, the concept
that saturated fatty acids activate TLR4 is not universally accepted. For example, functional TLR4
was necessary to attenuate trans fatty acid-induced obesity, hyperglycemia, and hyperinsulinemia
(37). Similarly, mice lacking MyD88, a TLR4 signaling adaptor protein, were more susceptible to
diet-induced insulin resistance, suggesting a protective role for MyD88 signaling in obesityassociated insulin resistance (38). Finally, in vitro studies suggest that TLR4 activation by fatty
acids can potentially be confounded by LPS and lipopeptide contamination (39).
In summary, myeloid-specific ABCA1 deficiency impairs cholesterol efflux, but does not
significantly exacerbate macrophage infiltration and low-grade inflammation in adipose tissue, or
insulin resistance in both HF diet-induced and genetically obese mouse models. However, because
we examined advanced obesity resulting from 17 weeks of HF diet feeding, we cannot rule out the
possibility that myeloid-specific ABCA1 deficiency might worsen adipose inflammation or
metabolic abnormalities in the context of less advanced obesity.
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Figures and Tables
Fig. 1.

Myeloid-specific ABCA1 deficiency increases cholesterol accumulation but does not enhance
obesity-associated inflammation in peritoneal macrophages. Mice were euthanized and resident
peritoneal macrophages were isolated for quantification of cholesterol by gas-liquid
chromatography or gene expression by quantitative real-time PCR. A, C: FC and CE content of
resident peritoneal macrophages from WT and MSKO mice fed the HF diet for 24 weeks. B, D:
FC and CE content in resident peritoneal macrophages from 14-week-old chow-fed ob/ob and
MSKO-ob/ob mice. E, F: Cytokine and chemokine mRNA expression in resident peritoneal
macrophages from HF diet-fed WT and MSKO mice (E) and chow-fed ob/ob and MSKO-o/ob
mice (F). G, H: TLR4 and CD36 mRNA expression in resident peritoneal macrophages from HF
diet-fed WT and MSKO mice (G) and chow-fed ob/ob and MSKO-o/ob mice (H). *P < 0.05;
**P < 0.01; ***P < 0.001. ns, no significance. +/+, WT; −M/−M, MSKO.

Fig. 2.

Myeloid-specific ABCA1 deficiency does not worsen insulin resistance in HF diet-fed mice.
Male mice, 8–9 weeks old, were fed a HF diet consisting of 45% calories from lard and 0.015%
cholesterol for 24 weeks. A: BW over the 24 week diet feeding period. B: Fasting plasma
glucose was measured after 20 weeks of HF diet consumption, after a 5 h fast. GTTs (C) and
ITTs (D) were performed after 20 weeks of HF diet feeding. Plasma insulin levels of fed (E) or
fasted (overnight) (F) mice were measured after 20 weeks of HF diet feeding. +/+, WT; −M/−M,
MSKO.

Fig. 3.

Myeloid-specific ABCA1 deficiency does not worsen insulin resistance in male ob/ob mice.
MSKO mice were crossed with ob/ob mice to induce obesity. A, B: BW was measured at 8 and
14 weeks of age. GTTs (C) and ITTs (D) were performed at 13 and 14 weeks of age,
respectively. Plasma insulin levels in fed (E) or overnight-fasted (F) mice were measured at 13
weeks of age.

Fig. 4.

Myeloid-specific ABCA1 deficiency does not worsen adipose macrophage infiltration and
inflammation in HF diet-fed mice. A: Epididymal fat mRNA expression of macrophage markers
(F4/80 and CD68) from mice fed the HF diet for 17 weeks and mice fed the chow diet for 20
weeks. B: Macrophages in adipose tissue were visualized by immunohistochemistry staining
using CD68 antibody (objective magnification ×10). CD68+ cells were quantified by Image-Pro

software. Data are presented as percentage of total area that is CD68+. C, D: Epididymal fat
mRNA expression of TNF-α, MCP-1, arginase I, and Ch3l3 from mice fed chow for 20 weeks or
HF diet for 17 weeks. Data are expressed as mean ± SEM. *P < 0.05. ***P < 0.001. ns, no
significance. +/+, WT; −M/−M, MSKO.

Fig. 5.

Myeloid-specific ABCA1 deficiency does not worsen adipose macrophage infiltration and
inflammation in ob/ob mice. A: Percentage of macrophages (F4/80+), M1 macrophages

(F4/80+CD11C+), or M2 macrophages (F4/80+CD206+) in stromal vascular cells isolated from
ob/ob epididymal fat. Data are expressed as mean ± SEM. B: Epididymal fat mRNA expression
of macrophage markers and inflammatory cytokines and chemokines from chow-fed 14-weekold MSKO-ob/ob and ob/ob mice. Data are expressed as mean ± SEM. C: FC and CE content in
stromal vascular cells (SVF). Data are expressed as mean ± range. *P < 0.05. ns, not
significantly different.

Fig. 6.

Myeloid-specific ABCA1 deficiency does not alter plasma and liver lipid homeostasis in the
setting of obesity. A, C: Blood samples from HF diet-fed mice were collected periodically to
assay total cholesterol (TC) and TGs by enzymatic assays. B, D: Blood samples were collected
from 14-week-old MSKO-ob/ob and ob/ob mice to assay TC and TGs by enzymatic assays. E–
H: After 24 weeks HF diet consumption or at the age of 14 weeks for ob/ob mice, mice were
euthanized and liver lipids were quantified by enzymatic assay and normalized to liver protein
content. +/+, WT; −M/−M, MSKO.
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Supplemental Table I: High-fat diet composition
Ingredient
Casein
L-cysteine
Dextrin
Maltodextrin
Sucrose
Cellulose
Soybean oil
Lard
Hegsted Salts
Vitamin Mix
MtS-50 (Vitamin E)
Total
(calories)
% of Calories

Grams/100 g
23.30
0.35
8.00
11.30
20.13
5.82
2.90
20.50
5.0
2.50
0.20
100
472.9

Grams of fat

Grams of
carbohydrate

Grams of protein
23.30
0.35

8.00
11.30
20.13
2.90
20.50
2.50
23.40
210.6
45%

41.93
167.7
35%

23.65
94.6
20%

Supplemental Figure 1. Liver (A and C) and epididymal fat (B and D) mass from mice consuming the HF
diet for 24 wks or chow-fed mice crossed into the ob/ob background (14 wks old). +/+= WT; -M/M=MSKO.
Supplemental Figure 2. Immunohistochemical staining and quantification of cleaved caspase-3 positive
cells (apoptotic) in adipose tissues from mice fed a HF diet for 17 wks (objective magnification ×10).
Cleaved caspase-3 positive cells were quantified using Image Pro software. ns= not statistically
significant. ns= not significant; p>0.05.

Supplemental Figure 3. (A) mRNA expression of F4/80 and CD68 in epididymal fat from mice consuming
a HF diet for 24 wks. (B) mRNA expression of TLR4 and CD36 in epididymal fat from mice consuming
chow (20 wks) or HF diet (17 wks). (C) mRNA expression of inflammatory cytokines/chemokines in
epididymal fat from mice consuming a HF diet for 24 wks. Gene expression was evaluated by
quantitative real-time PCR. +/+= WT; -M/-M=MSKO. ns= not significant; p>0.05.
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